LWM
CXM

Lyons Wealth Management’s CARDIUM THERAPEUTICS INC NEW CXM Stock Holding History

Lyons Wealth Management’s Portfolio CXM Stock Details CXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,707
Closed -$2K – 111
2013
Q2 		$2K Buy
+1,707
New +$3.07K ﹤0.01% 81

Other funds holding CXM

Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return

Lyons Wealth Management's CXM Position: Q3 2013 in Review

Lyons Wealth Management sold out of CARDIUM THERAPEUTICS INC NEW (CXM) in Q3 2013, closing a stake of 1,707 shares — an estimated $2K sold.

Lyons Wealth Management first reported a position in CXM in Q2 2013 and held it in 1 quarter. The position peaked at $2K in Q2 2013. 8 funds tracked by Wall St. Rank hold CXM as of Q3 2013.

  • Lyons Wealth Management reported no remaining CARDIUM THERAPEUTICS INC NEW position as of Q3 2013 after selling out during the quarter.
  • Lyons Wealth Management sold 1,707 CARDIUM THERAPEUTICS INC NEW shares in Q3 2013, an estimated $2K.
  • Lyons Wealth Management first reported a position in CARDIUM THERAPEUTICS INC NEW in Q2 2013 and held it in 1 quarter.
  • Lyons Wealth Management's CARDIUM THERAPEUTICS INC NEW position peaked at $2K in Q2 2013.
  • 8 funds tracked by Wall St. Rank held CARDIUM THERAPEUTICS INC NEW as of Q3 2013.

Based on Lyons Wealth Management's 13F filing for Q3 2013, filed 12 Nov 2013.